DAVID DREYER, CPA
Chief Financial Officer
Mr. David C. Dreyer CPA has almost 30 years of accounting, financial, compliance and operating experience and expertise in the healthcare field and has extensive senior leadership experience.
Previously Mr. Dreyer was Chief Financial Officer between March 2015 to January 2017 for BIOLASE, Inc. (NASDAQ:BIOL), a medical device company that develops, manufactures, and markets innovative lasers used in dentistry. Between 2010 to 2015, Mr. Dreyer served as Chief Financial Officer, Chief Operating Officer and Secretary of Patient Safety Technologies, which develops, markets and sells healthcare products relating to surgical safety, and was a former public reporting company (OTC: PSTX). Since March 2014, Patient Safety became a subsidiary of Stryker Corporation (NYSE: SYK).
Between 2004 to 2009, Mr. Dreyer was Chief Financial Officer of AMN Healthcare Services, Inc. (NYSE: AHS), which provides healthcare staffing in hospitals including physicians, travel nurses, and allied travel. From 1997 through 2004, Mr. Dreyer served as Chief Financial Officer and Chief Accounting Officer of Sicor, Inc. (formerly Nasdaq: SCRI), a manufacturer of complex pharmaceuticals with operations in the United States and internationally, which was acquired by Teva Pharmaceutical Limited in January 2004. Prior to joining Sicor, Mr. Dreyer served in related senior financial management positions within the pharmaceutical industry, working for Elan Corporation plc, Athena Neurosciences and Syntex Corporation. Mr. Dreyer is a Certified Public Accountant in California. Mr. Dreyer has also been a director of InfuSystem Holdings, Inc. (NYSE:INFU), a leading national provider of infusion pumps and related services, since April 2008, and also a director since September 2014 of Diplomat Pharmacy Inc., the nation’s largest independent specialty pharmacy company in the US.